Sana Biotechnology Files Form 4 on Ownership Changes
Ticker: SANA · Form: 4 · Filed: 2026-04-08T16:16:24-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
Related Tickers: SANA
TL;DR
Sana Bio (SANA) filed a Form 4 on 4/8/26 for 4/6/26 transactions. Ownership changes reported.
AI Summary
On April 8, 2026, Sana Biotechnology, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The report covers transactions that occurred on April 6, 2026. The filing details are associated with CIK 0001770121 and relate to the company's operations in biological products.
Why It Matters
Form 4 filings are crucial for investors as they disclose insider transactions, providing insights into the confidence or concerns of company executives and major shareholders.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of changes in beneficial ownership and does not inherently indicate new risks for the company.
Key Players & Entities
- Sana Biotechnology, Inc. (company) — Issuer
- 0001770121 (company) — Issuer CIK
- 0001480212-26-000004 (company) — SEC Accession Number
- 2026-04-08 (date) — Filing Date
- 2026-04-06 (date) — Period of Report
- Bishop Hans Edgar (person) — Reporting Person
FAQ
What type of SEC filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-08 at 16:16:24.
What is the CIK for Sana Biotechnology, Inc.?
The CIK for Sana Biotechnology, Inc. is 0001770121.
What is the period of report for this filing?
The period of report is 2026-04-06.
What is the business address of Sana Biotechnology, Inc.?
The business address is 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA.
From the Filing
EDGAR Filing Documents for 0001480212-26-000004 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001480212-26-000004 Filing Date 2026-04-08 Accepted 2026-04-08 16:16:24 Documents 1 Period of Report 2026-04-06 Document Format Files Seq Description Document Type Size 1 PRIMARY DOCUMENT primarydocument.html 4 1 PRIMARY DOCUMENT primarydocument.xml 4 3544 Complete submission text file 0001480212-26-000004.txt 4974 Mailing Address 188 EAST BLAINE STREET SUITE 400 SEATTLE WA 98102 Business Address Bishop Hans Edgar ( Reporting ) CIK : 0001480212 (see all company filings) Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 26848316 Mailing Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA Business Address 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA (206) 701-7914 Sana Biotechnology, Inc. ( Issuer ) CIK : 0001770121 (see all company filings) EIN. : 831381173 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)